Preimplantation genetic diagnosis for myotonic dystrophy type 1: upon request to child.
Preimplantation genetic diagnosis (PGD) is an alternative to prenatal diagnosis for patients at risk of transmitting an inherited disease such as myotonic dystrophy type 1(DM1) to their offspring. In this paper, the clinical application of preimplantation diagnosis for DM1 upon request to children born is described in a large cohort of risk couples. PGD could be offered to all 78 couples opting for PGD regardless of the triplet repeat size. The incidence of major complications was minimalised following a careful assessment in affected DM1 females anticipating possible cardiological, obstetrical and anaesthetical problems. A live-birth delivery rate per cycle with oocyte retrieval of 20% was the outcome. Forty-eight of the 49 children born are in good health and have normal psychomotor development.
De Rademaeker
Marjan
M
Centre for Medical Genetics, Universitair Ziekenhuis Brussel, Belgium. marjan.derademaeker@uzbrussel.be
Verpoest
Willem
W
De Rycke
Martine
M
Seneca
Sara
S
Sermon
Karen
K
Desmyttere
Sonja
S
Bonduelle
Maryse
M
Van der Elst
Josianne
J
Devroey
Paul
P
Liebaers
Inge
I
D000328:Adult; D005260:Female; D005307:Fertilization in Vitro; D005820:Genetic Testing; D006801:Humans; D009223:Myotonic Dystrophy / Q000175:diagnosis*; D011247:Pregnancy; D011256:Pregnancy Outcome; D019836:Preimplantation Diagnosis